S&P 500 gained 17.6% in 2025 led by Tech & AI tailwinds. Click for my full review of the changes made to my holdings and what ...

SFLO ETF review: top-quartile small-cap value returns, strong ROTC, but Energy volatility and weak earnings durability risks.

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. My ...

The rebound that began in April on stock markets around the world is leading to a positive double-digit year-end close for ...

Global markets endured a volatile run in 2025, but when the last trades closed on Dec. 31, all the major asset classes posted ...

Seeking Alpha’s 2025 year in review spotlights the stories that mattered most to subscribers, tracking the headlines that ...

Discover how the AFC Asia Frontier Fund hit record NAV in 2025 with +17.5% returns. Learn about its low valuations and ...

Series D & J—with strong dividend coverage and moderate redemption risk. Read my analysis of SCHW and its preferreds.

My biotech-focused portfolio delivered a 34.3% average return, outperforming the S&P 500 by 20.6%. Click here for a detailed ...

Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...

UnitedHealth (UNH) stock is in focus as the company gets results of its first outside reviews. Read more here.

Axsome Therapeutics (AXSM) stock gains as the FDA grants priority review to expand its depression drug Auvelity for Alzheimer ...